🔴 Absci is trading 5.94% down today amid unexplained reversal

Absci is trading at $9.73, with a change of -5.94%, in an unexplained reversal after recent volatility.

• No new company-specific announcement explaining the September 25 decline was identified.
• The September 24 ABS-201 STORYLINE Phase 2 update described a planned endometriosis trial, but was tied to the prior session’s advance, not today’s drop.
• Broader indexes were near flat, and evidence was insufficient to attribute the decline to macro sentiment.